Product/Composition:- | Fresh Frozen Plasma (FFP) powder for reconstitution or liquid |
---|---|
Strength:- | available in 200-250 mL units |
Form:- | liquid units or lyophilized (freeze-dried) powder |
Reference Brands:- | No specific brands |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Frozen Plasma (FFP) provides all essential coagulation factors, volume, and plasma proteins. It corrects coagulopathies, restores blood volume, and supports clot formation. Benefits include rapid correction of clotting deficiencies, effective bleeding control, improved hemodynamic stability, and support during surgeries or trauma, enhancing patient recovery.
Frozen Plasma (FFP), used for coagulation correction and volume resuscitation, is regulated in the US by the FDA and in the EU via EMA approval pathways. Regulatory approval requires a comprehensive dossier including manufacturing standards, donor screening, safety, efficacy, and pharmacovigilance plans. In the US, FDA review assesses clinical and quality data, while EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regulatory compliance is essential for the safe, effective, and timely approval of FFP products worldwide, supporting optimal patient care in critical bleeding and coagulation disorders.